Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation. (Q46873552)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Mary Ann Suico

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Takashi Sato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Seiko Susuki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Fumi Mikami

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Shinji Ikemizu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Masaaki Nakamura

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Makoto Anraku

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Toshiya Kai

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Tsuyoshi Shuto

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Mineyuki Mizuguchi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yuriko Yamagata

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hirofumi Kai

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yukio Ando

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

22 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

580

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

491-496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16386248%20AND%20SRC:MED&resulttype=core&format=json

Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Familial amyloidotic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Comparison of Lethal and Nonlethal Transthyretin Variants and Their Relationship to Amyloid Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Therapeutic strategies for human amyloid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Rational design of potent human transthyretin amyloid disease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

The effect of iodide and chloride on transthyretin structure and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Inhibiting transthyretin amyloid fibril formation via protein stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

The metallobiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Prevention of transthyretin amyloid disease by changing protein misfolding energetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Chromium(III)-mediated structural modification of glycoprotein: impact of the ligand and the oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Inhibiting transthyretin conformational changes that lead to amyloid fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Chromium as an essential nutrient for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

The Tetrameric Protein Transthyretin Dissociates to a Non-native Monomer in Solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Comparative calorimetric study of non-amyloidogenic and amyloidogenic variants of the homotetrameric protein transthyretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047

Sequence Communication: Tabulation of transthyretin (TTR) variants as of 1/1/2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.12.047